Why the study?
Is there a correlation between platelet life-span and plasma concentrations of β-TG or PF-4 in patients with various diseases compared to healthy controls?
Population
97 individuals, comprising 28 normal subjects and 69 patients with various diseases.
Design
Cross-sectional
Authors
Loading...
May support β-TG/PF-4 as markers of platelet consumption; leaves open prospective outcome validation in IHD.
Is there a correlation between platelet life-span and plasma concentrations of β-TG or PF-4 in patients with various diseases compared to healthy controls?
Plasma concentrations of β-TG and PF-4 are reliable indicators of intravascular platelet consumption in various diseases, including ischemic heart disease and cerebral infarction.
Motoo Nagasaka (1986) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: